US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about NASDAQ:VVOS

Recent news which mentions NASDAQ:VVOS

VVOS Stock Earnings: Vivos Therapeutics Beats EPS, Beats Revenue for Q2 2024
Tickers VVOS
Tags VVOS NASDAQ:VVOS Market News
From InvestorPlace
VVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024
Tickers VVOS
Tags Market News NASDAQ:VVOS Earnings Reports
From InvestorPlace
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
Tags NASDAQ:VVOS
From News Direct
VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023
Tickers VVOS
Tags Earnings Reports Market News NASDAQ:VVOS
From InvestorPlace
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics secures Middle East-North Africa distribution deal and Stanford study
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics highlights 1Q financial and operational growth with major acquisition
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics talks clinical study success of POD migraine treatment, new timeline for cashflow
Tags NASDAQ:VVOS
From News Direct
Vivos Therapeutics vs. ResMed: Which Sleep Apnea Stock is a Better Buy?
Tags NASDAQ:VVOS NYSE:RMD
From StockNews.com